Equities
Health CareHealth Care Providers
  • Price (CAD)1.47
  • Today's Change0.09 / 6.52%
  • Shares traded414.23k
  • 1 Year change-38.24%
  • Beta-1.0374
Data delayed at least 15 minutes, as of Jul 14 2025 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Healwell Al Inc. is a Canada-based healthcare artificial intelligence (AI) company focused on preventative care. The Company, using its own proprietary technology, is developing and commercializing advanced clinical decision support systems that can help healthcare providers detect rare and chronic diseases. The Company's segments include Clinical Research and Patient services, AI and Data sciences and Healthcare Software. The Clinical Research and Patient Services segment includes clinical research contracts and medical consultations provided through the Company's MCI Polyclinic Group Inc. and BioPharma subsidiaries in Ontario. The AI and Data Sciences segment includes integration of advanced AI and data science technologies in healthcare through its Khure Health Inc. and Pentavere and Mutuo subsidiaries. The Healthcare Software segment includes Intrahealth and Versource healthcare software-as-a-service.

  • Revenue in CAD (TTM)48.48m
  • Net income in CAD-34.08m
  • Incorporated2020
  • Employees350.00
  • Location
    Healwell Al Inc4881 Yonge Street, Suite 300Toronto M2N5X3CanadaCAN
  • Phone+1 (905) 960-6717
  • Websitehttps://healwell.ai/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
AIDX:TOR since
announced
Transaction
value
Orion Health Holdings LtdDeal completed16 Dec 202416 Dec 2024Deal completed-36.64%115.60m
Data delayed at least 15 minutes, as of Jul 14 2025 21:00 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Tactile Systems Technology Inc401.36m22.17m317.01m1.04k14.991.1410.030.78980.66460.664612.168.721.067.277.70282,704.005.861.296.701.5550.7849.125.521.263.99--0.11010.006.769.11-40.529.10-15.97--
OraSure Technologies Inc221.27m-43.75m317.46m501.00--0.5876--1.43-0.4274-0.42742.175.280.34942.385.82322,606.80-6.43-0.8506-6.83-0.959641.8444.80-18.40-1.3910.94--0.0004---54.173.75-136.34---16.43--
Neuronetics Inc122.46m-66.41m321.70m716.00--6.63--2.63-1.32-1.322.250.53860.72786.064.09124,927.40-39.50-29.61-47.97-36.9663.5174.98-54.27-53.712.28-4.830.5833--4.963.63-44.78--12.51--
MaxCyte Inc51.58m-57.21m323.43m114.00--1.18--6.27-0.3968-0.39680.35781.880.15440.71116.54330,491.20-17.13-13.01-18.10-14.0180.9187.32-110.92-72.4311.58--0.00---6.4412.31-8.26--5.37--
908 Devices Inc84.08m-97.38m340.72m246.00--1.56--4.05-2.05-0.53911.774.460.31842.138.52249,662.60-36.87-18.01-41.00-19.6749.6052.89-115.81-78.456.97--0.00--18.7227.11-98.37--8.96--
ZimVie Inc607.24m-34.08m344.03m1.77k--0.635626.130.5666-0.9038-0.708416.0814.160.46272.016.09250,593.80-2.60-3.72-3.05-4.2264.8364.16-5.61-10.871.480.08780.3583---1.68-15.6939.64---33.91--
Alpha Teknova Inc52.37m-31.89m351.91m173.00--3.27--6.72-0.4713-0.47130.76681.470.32583.407.52221,098.30-19.84-19.57-21.11-20.9720.9938.24-60.90-63.704.71-33.710.1418--2.8912.6827.28---16.96--
Alpha Tau Medical Ltd0.00-44.44m354.83m125.00--3.83-----0.4629-0.46290.000.79880.00----0.00-35.40-34.28-38.97-36.47------------0.0886-------8.89--11.60--
Healwell Al Inc48.48m-34.08m366.35m350.00--3.80--7.56-0.2992-0.29940.34290.36350.3272--8.55138,514.30-23.77-36.75-30.60-56.7644.2735.09-72.64-65.92---10.140.4649--432.62-3.3818.49--60.84--
Quanterix Corp185.76m-65.54m376.21m471.00--0.7223--2.03-1.24-1.243.528.150.33471.834.72288,084.90-11.81-13.18-12.98-14.5359.6756.14-35.28-45.097.53--0.00--12.3019.36-35.89---20.86--
Cerus Corp283.09m-25.94m379.48m281.00--4.99--1.34-0.1019-0.10191.110.29041.041.858.46735,868.30-9.59-20.38-14.20-31.9660.6061.15-9.18-25.371.63-1.370.6017--7.7816.5144.20---20.50--
SANUWAVE Health Inc49.55m-44.52m408.03m46.00------8.24-6.89-6.896.07-2.021.342.1410.53786,739.10-120.05-124.81----76.6371.67-89.86-144.710.28290.16292.98--59.9999.65-21.56--55.47--
Pheton Holdings Ltd613.61k-904.38k409.88m10.00--48.41--667.99-0.0517-0.05170.03520.4340.10750.79021.8444,820.00-15.84---20.03--85.04---147.39--12.18--0.0386---28.70---173.85------
Neuropace Inc115.42m-33.96m427.47m195.00--12.85--3.70-0.8304-0.83042.820.7410.80651.706.23458,184.80-23.73-35.71-27.37-44.3474.8373.39-29.42-60.455.70-3.380.7113--22.1416.6717.64---8.15--
Clearpoint Neuro Inc44.13m-28.47m441.14m115.00--15.96--10.00-0.7534-0.75341.170.71430.77021.729.11280,313.00-49.68-35.94-67.42-41.4861.2063.49-64.51-74.872.57--0.00--31.0422.8514.37--11.41--
Data as of Jul 14 2025. Currency figures normalised to Healwell Al Inc's reporting currency: Canadian Dollar CAD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.